Spro earnings date

Author: hens

August undefined, 2024

Web15 Jun 2024 · Insider Trading Dashboard. Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on insider trading activity, which can give hints on whether executives are bullish or bearish on their own companies.

SmartPros (SPRO) Earnings Date - StockEarnings.com

WebThe latest earnings, revenues and financial reports for Spero Therapeutics (SPRO). Download the App More markets insights, more alerts, more ways to customise assets watchlists only on the App WebStep 1) Enter transaction code “OBC4” in the SAP command field and enter to continue. Step 2) On change view “field status variants” overview screen, select the FSTV 0001 and than select the copy as button. Step 3) Now change the variant name to TKFV and name to Field status for TKFV. Press enter to continue chromium network

Spero Therapeutics (SPRO) Earnings Dates & Reports

WebSpero Therapeutics, Inc. (SPRO) NasdaqGS - NasdaqGS Real-time price. Currency in USD Add to watchlist 1.4800 -0.0300 (-1.99%) At close: 04:00PM EST 1.4900 +0.01 (+0.68%) … WebSPRO Earnings Forecast Next quarter’s earnings estimate for SPRO is -$0.28 with a range of -$0.31 to -$0.26. The previous quarter’s EPS was $0.55. SPRO beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.36% of the time in the same period. WebEarnings Date 05/15/2024 (est) Ex Div Date - Div Amount - Split Date - Split Factor - ANALYST CONSENSUS Make data-driven investment decisions using cutting-edge … chromium next gem

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Beat …

Spero Therapeutics (SPRO) Stock Forecast & Price Target

Web12 Jul 2009 · Pinned Tweet. BioPharmCatalyst. @BPharmCatalyst. ·. Jun 10, 2024. BioPharmCatalyst is the website for trading #biotech - Track +1300 drug and medical device catalysts from +800 companies - Analyze company cash data, upcoming IPOs and more - Connect to a community of traders Be There When it Happens: Web3 Nov 2024 · SPRO chart Today −5.84% Week 4.32% 1 month −2.03% 6 months −29.27% Year to date −17.14% 1 year −78.96% 5 years −89.79% All time −89.06% Key stats Market capitalization 76.229M USD Dividends yield (FY) — Price to earnings Ratio (TTM) — Basic EPS (TTM) −1.65 USD About Spero Therapeutics, Inc ISIN US84833T1034 Sector Health … chromium network serviceWeb14 Apr 2024 · April 14, 2024 - 8:05 am. CAMBRIDGE, Mass., April 14, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant … chromium new tab blank

"Web12 Apr 2024 · The ex-dividend date of this dividend is Tuesday, April 11th. ... Spero Therapeutics, Inc. (NASDAQ:SPRO) Expected to Earn Q1 2024 Earnings of ($0.37) Per Share ... Alcoa (AA) to Release Quarterly ... " - Spro earnings date

Spro earnings date

Spero Therapeutics to Present Data at the 33rd European …

WebCompany’s earnings for a period net of operating costs, taxes, and interest. 26.77M. 191.56%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue ... WebSmartPros (SPRO) Earnings Date. SmartPros has confirmed Earnings date and time. It is on Thu 30 Mar (In 12 Days). The Algorithm predicts "% Predicted Move After Earnings …

Did you know?

WebThe earnings calendar allows you to sort earnings by market cap, deep dive on estimates and learn historical data for your favorite stocks. Use the earnings calendar to get latest earnings... Web1 day ago · CAMBRIDGE, Mass., April 14, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced two …

Web10 Aug 2024 · Earnings History: Past Earnings Statistics and Earnings Trendline At OptionSlam.com we make a concerted effort to provide the most accurate Earnings … WebRetained Earnings Account OB53 22. Tolerance Group for G/L Account OBA0 23. Tolerance Group for Employees OBA4 24 ... Specify parameters for date transfer SPRO 80. Creation of Depreciation of Key 5 Steps 1.

Web6 Apr 2024 · Key Earnings Data Earnings ESP 0.00% Most Accurate Est -0.26 Current Qtr Est -0.26 Current Yr Est -1.13 Exp Earnings Date 5/15/23 Prior Year EPS -1.23 Exp EPS Growth (3-5yr) NA Forward PE... WebDate Title; Mar 31: Spero Therapeutics, Inc. (SPRO) Q4 2024 Earnings Call Transcript: Mar 30: Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Beat Estimates: Mar 30: Spero Therapeutics GAAP EPS of $0.55 beats by $0.51, revenue of $47.44M beats by $24.57M: Mar 30

Web11 Jul 2011 · you use the report RPUCTP00 (Generate Payroll Periods) to generate the date specifications for a selected period for the payroll periods that are to be valid in your system. For each period parameter that is assigned to apayroll area, the system requires the following date specifications: Start date and end date of each payroll period

WebEarnings Peers: Spero Therapeutics (SPRO) is categorized under the Healthcare sector; to help you further research next earnings dates across stocks, below are some other … chromium next gem single cellWeb1 day ago · RBC Capital Markets annonce que les actions du Fonds fiduciaire d'uranium physique Spro.. 03/31: Atha Energy Corp. a conclu l'acquisition d'un porte.. 03/22: RBC Marchés des Capitaux déclare que le cours de l'action de Sprott Physical Uranium es.. 02/26: Nexgen Energy (Canada) réduit sa perte pour 2024 en raison d'une perte moindre sur les ... chromium new featuresWebOver the past 65 months, SPRO's price/earnings ratio has gone up 3.7. Below are key valuation metrics over time for SPRO. SPRO's Quality Factors The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. chromium neutron countWeb12 Apr 2024 · The consensus estimate for Fastenal’s current full-year earnings is $1.95 per share. KeyCorp also issued estimates for Fastenal’s FY2024 earnings at $2.01 EPS. FAST has been the subject of ... chromium next gem chip gWebSpero Therapeutics Market Cap: 63.47M, Enterprise value: 21.28M, P/E: -0.52, PEG ratio: -0.03, EPS: -3.49, Revenue: 8.77M, EBITDA: -107.90M, Income: -113.27M, Profit ... chromium next gem chip k single cell kitWeb15 hours ago · CAMBRIDGE, Mass., April 14, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. SPRO, a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today … chromium next gem chip g single cell kitWebEarnings Date 05/15/23 Sector Healthcare Industry Biotechnology Avg. Analyst Rec. Premium Beta 2.204 PEG Ratio — Spero Therapeutics Inc. (SPRO) Company Description Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. chromium next gem secondary holder